By Mary Stuart
Obstructive sleep apnea has been, until recently, somewhat of a silent epidemic (except for the snoring). But at the tail...
There's a reason why Philips paid $5 billion and a premium to buy Respironics. Sleep apnea is an enormous emerging opportunity: in the US, 38 million patients have the disease, and there are compelling clinical reasons to treat them. That's big business for device companies, if only they can access patients and establish new referral patterns in a highly fragmented market.
By Mary Stuart
Obstructive sleep apnea has been, until recently, somewhat of a silent epidemic (except for the snoring). But at the tail...
The last steps are taking place leading to the launch of the EU’s medical device database, EUDAMED.
CEO Alexandre Chau told Medtech Insight that the Middle East and Africa presented the ideal mix of market potential, physician training opportunities, and regulatory readiness when the company was considering expansion markets beyond Europe and the US.
Researchers at Johns Hopkins have used a robotic system to autonomously perform a key part of gallbladder surgery without a surgeon's hand. Lead author Axel Krieger says it could take five to 10 years before an autonomous robotic system will reach human trials and expects regulatory hurdles.